Dr. Alice Chen Fan, MD

Dr. Fan practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Fan's NPI, 1871524454, was assigned on July 5, 2006. Dr. Fan graduated from Albany Medical College in 1998. Dr. Fan holds California license A74466.

Dr. Fan's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Fan's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Fan is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Fan to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Fan's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fan practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Fan's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Fan is board certified in internal medicine by the American Board of Internal Medicine. Dr. Fan is licensed in California.

Dmand AI lists lung cancer, lymphoma and prostate cancer among the conditions Dr. Fan treats.

CMS data shows 472 Medicare services from Dr. Fan across 4 procedure codes in 2024, for 195 Medicare patients. Medicare paid $47,917 for them.

CMS counts 195 Medicare patients who saw Dr. Fan in 2024. The largest group is 75 to 84, with 93 patients. 75% of them have cancer, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fan's median patient age at 68, with 24% women.

In 2024, Dr. Fan wrote 110 Medicare Part D claims for 39 patients. 75% of them were for generic drugs. CMS names the drug for 65 of them, across 4 drugs with 11 or more claims each, at $592,266 in total drug cost. In 2023, CMS named 67 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Fan for performance year 2024, reported as part of a group. Dr. Fan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fan as offering telehealth.

Dmand AI links 73 papers to Dr. Fan, published from 2006 to 2024. 2019 was the busiest year, with 8. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Mice, Transgenic. Dr. Fan has published most often in Proc Natl Acad Sci U S A. Dr. Fan's most frequent co-authors are Dean Felsher, MD, Heather Ann Wakelee, MD and John Thomas Leppert, MD.

Dmand AI links Dr. Fan to 8 clinical trials, 5 of them phase 2 studies. Conditions studied include Carcinoma, Renal Cell, Kidney Neoplasms and Lymphoma, Non-Hodgkin. Calithera Biosciences, Inc sponsors the most, 3.

CMS Open Payments shows 12 general payments to Dr. Fan from 6 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 83% of the total. Novartis Pharmaceuticals Corporation paid the most, $5,514.

Dmand AI lists 1 award for Dr. Fan, most recently CMS Stage 1 EHR in 2013.

Dr. Fan graduated from Albany Medical College in 1998. Dr. Fan is a member of ASCO.

Dr. Fan is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.